Compare APOG & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APOG | MLAB |
|---|---|---|
| Founded | 1949 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 794.2M | 719.9M |
| IPO Year | 1994 | 1995 |
| Metric | APOG | MLAB |
|---|---|---|
| Price | $48.01 | $140.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | ★ $45.50 | N/A |
| AVG Volume (30 Days) | ★ 246.9K | 78.5K |
| Earning Date | 10-06-2026 | 11-09-2026 |
| Dividend Yield | ★ 2.26% | 0.47% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | ★ 1.61 | 1.25 |
| Revenue | ★ $1,404,733,000.00 | N/A |
| Revenue This Year | $5.63 | $2.30 |
| Revenue Next Year | $6.57 | $4.41 |
| P/E Ratio | ★ $29.76 | $109.46 |
| Revenue Growth | ★ 3.21 | N/A |
| 52 Week Low | $30.75 | $69.51 |
| 52 Week High | $50.88 | $144.35 |
| Indicator | APOG | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 66.88 | 63.72 |
| Support Level | $37.05 | $120.65 |
| Resistance Level | $50.88 | $144.35 |
| Average True Range (ATR) | 1.60 | 5.61 |
| MACD | 0.13 | 1.19 |
| Stochastic Oscillator | 78.99 | 94.55 |
Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company geographically operates in the United States, Canada, and Brazil, with the majority revenue generated from the United States.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.